• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌细胞表面Nectin-4的表达改变了它们的黏附、迁移、聚集和增殖能力。

The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.

作者信息

Boylan Kristin L M, Buchanan Petra C, Manion Rory D, Shukla Dip M, Braumberger Kelly, Bruggemeyer Cody, Skubitz Amy P N

机构信息

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.

出版信息

Oncotarget. 2017 Feb 7;8(6):9717-9738. doi: 10.18632/oncotarget.14206.

DOI:10.18632/oncotarget.14206
PMID:28038455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354766/
Abstract

The cell adhesion molecule Nectin-4 is overexpressed in epithelial cancers, including ovarian cancer. The objective of this study was to determine the biological significance of Nectin-4 in the adhesion, aggregation, migration, and proliferation of ovarian cancer cells. Nectin-4 and its binding partner Nectin-1 were detected in patients' primary tumors, omental metastases, and ascites cells. The human cell lines NIH:OVCAR5 and CAOV3 were genetically modified to alter Nectin-4 expression. Cells that overexpressed Nectin-4 adhered to Nectin-1 in a concentration and time-dependent manner, and adhesion was inhibited by antibodies to Nectin-4 and Nectin-1, as well as synthetic Nectin peptides. In functional assays, CAOV3 cells with Nectin-4 knock-down were unable to form spheroids and migrated more slowly than CAOV3 parental cells expressing Nectin-4. NIH:OVCAR5 parental cells proliferated more rapidly, migrated faster, and formed larger spheroids than either the Nectin-4 knock-down or over-expressing cells. Parental cell lines expressed higher levels of epithelial markers and lower levels of mesenchymal markers compared to Nectin-4 knock-down cells, suggesting a role for Nectin-4 in epithelial-mesenchymal transition. Our results demonstrate that Nectin-4 promotes cell-cell adhesion, migration, and proliferation. Understanding the biology of Nectin-4 in ovarian cancer progression is critical to facilitate its development as a novel therapeutic target.

摘要

细胞黏附分子Nectin-4在包括卵巢癌在内的上皮癌中过表达。本研究的目的是确定Nectin-4在卵巢癌细胞黏附、聚集、迁移和增殖中的生物学意义。在患者的原发性肿瘤、网膜转移灶和腹水细胞中检测到了Nectin-4及其结合伴侣Nectin-1。对人细胞系NIH:OVCAR5和CAOV3进行基因改造以改变Nectin-4的表达。过表达Nectin-4的细胞以浓度和时间依赖性方式黏附于Nectin-1,并且Nectin-4和Nectin-1的抗体以及合成的Nectin肽可抑制黏附。在功能试验中,Nectin-4敲低的CAOV3细胞无法形成球体,并且比表达Nectin-4的CAOV3亲本细胞迁移得更慢。与Nectin-4敲低细胞相比,NIH:OVCAR5亲本细胞增殖更快、迁移更快并且形成更大的球体。与Nectin-4敲低细胞相比,亲本细胞系表达更高水平的上皮标志物和更低水平的间充质标志物,这表明Nectin-4在上皮-间充质转化中起作用。我们的结果表明,Nectin-4促进细胞间黏附、迁移和增殖。了解Nectin-4在卵巢癌进展中的生物学特性对于促进其作为新型治疗靶点的开发至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/59aee75d804d/oncotarget-08-9717-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/5176cfddb8a1/oncotarget-08-9717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/a1d2599356a3/oncotarget-08-9717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/d50c67dc11f8/oncotarget-08-9717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/96eacdaff9fe/oncotarget-08-9717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/e5a107602d14/oncotarget-08-9717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/3f6c01593779/oncotarget-08-9717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/17fcc23d212d/oncotarget-08-9717-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/551f17223d31/oncotarget-08-9717-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/c7862e8f2bd9/oncotarget-08-9717-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/59aee75d804d/oncotarget-08-9717-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/5176cfddb8a1/oncotarget-08-9717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/a1d2599356a3/oncotarget-08-9717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/d50c67dc11f8/oncotarget-08-9717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/96eacdaff9fe/oncotarget-08-9717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/e5a107602d14/oncotarget-08-9717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/3f6c01593779/oncotarget-08-9717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/17fcc23d212d/oncotarget-08-9717-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/551f17223d31/oncotarget-08-9717-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/c7862e8f2bd9/oncotarget-08-9717-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ef/5354766/59aee75d804d/oncotarget-08-9717-g010.jpg

相似文献

1
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.卵巢癌细胞表面Nectin-4的表达改变了它们的黏附、迁移、聚集和增殖能力。
Oncotarget. 2017 Feb 7;8(6):9717-9738. doi: 10.18632/oncotarget.14206.
2
Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4.来源于 nectin-4 的合成肽抑制卵巢癌细胞球体形成。
Int J Mol Sci. 2020 Jun 30;21(13):4637. doi: 10.3390/ijms21134637.
3
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.细胞黏附分子Nectin-4在卵巢癌中的胞外域脱落由ADAM10和ADAM17介导。
J Biol Chem. 2017 Apr 14;292(15):6339-6351. doi: 10.1074/jbc.M116.746859. Epub 2017 Feb 23.
4
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers.黏附分子 2 是用于治疗乳腺癌和卵巢癌的抗体疗法的一个潜在靶点。
Mol Cancer. 2013 Jun 12;12:60. doi: 10.1186/1476-4598-12-60.
5
Nectin-2 in ovarian cancer: How is it expressed and what might be its functional role?黏附连接蛋白 2 在卵巢癌中的表达及其功能作用研究进展
Cancer Sci. 2019 Jun;110(6):1872-1882. doi: 10.1111/cas.13992. Epub 2019 May 2.
6
Tage4/Nectin-like molecule-5 heterophilically trans-interacts with cell adhesion molecule Nectin-3 and enhances cell migration.Tage4/nectin样分子5与细胞黏附分子Nectin-3发生异嗜性反式相互作用并增强细胞迁移。
J Biol Chem. 2003 Jul 25;278(30):28167-72. doi: 10.1074/jbc.M303586200. Epub 2003 May 11.
7
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy.黏附连接蛋白 4(NECTIN-4):癌症治疗的潜在靶点。
Eur J Pharmacol. 2021 Nov 15;911:174516. doi: 10.1016/j.ejphar.2021.174516. Epub 2021 Sep 20.
8
Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.原发性腹膜癌肉瘤的一种新型细胞系以及已建立的卵巢癌细胞系对间质基质的侵袭:细胞-基质黏附分子、蛋白酶和E-钙黏蛋白表达的作用
Gynecol Oncol. 2003 Apr;89(1):60-72. doi: 10.1016/s0090-8258(02)00152-x.
9
Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.上皮-间质转化通过nectin-1增强对溶瘤性疱疹病毒疗法的反应。
Hum Gene Ther. 2014 Jun;25(6):539-51. doi: 10.1089/hum.2013.177. Epub 2014 Apr 2.
10
Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, Nectin-3-independent manner.Nectin样分子5/Tage4以整合素依赖性、Nectin-3非依赖性方式增强细胞迁移。
J Biol Chem. 2004 Apr 23;279(17):18015-25. doi: 10.1074/jbc.M312969200. Epub 2004 Feb 9.

引用本文的文献

1
Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment.未来的诊疗策略:新兴的卵巢癌生物标志物以弥合诊断与治疗之间的差距。
Front Drug Deliv. 2024 Feb 1;4:1339936. doi: 10.3389/fddev.2024.1339936. eCollection 2024.
2
Melanoma microsatellites exhibit a metastatic signature by spatial transcriptomics and overexpress mediators of immune evasion.黑色素瘤微卫星通过空间转录组学呈现转移特征并过表达免疫逃逸介质。
Virchows Arch. 2025 Jul 28. doi: 10.1007/s00428-025-04182-7.
3
A Peptide Derived from Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells from Ovarian Cancer Patients' Ascites.

本文引用的文献

1
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.细胞黏附分子Nectin-4在卵巢癌中的胞外域脱落由ADAM10和ADAM17介导。
J Biol Chem. 2017 Apr 14;292(15):6339-6351. doi: 10.1074/jbc.M116.746859. Epub 2017 Feb 23.
2
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models.恩福妥昔单抗抗体药物偶联物靶向 Nectin-4 是多种临床前癌症模型中一种高效的治疗药物。
Cancer Res. 2016 May 15;76(10):3003-13. doi: 10.1158/0008-5472.CAN-15-1313. Epub 2016 Mar 24.
3
It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.
一种源自NECTIN-4的肽可增强顺铂对卵巢癌细胞系及卵巢癌患者腹水细胞的细胞毒性。
Cancers (Basel). 2025 Mar 6;17(5):901. doi: 10.3390/cancers17050901.
4
Exosomal PVRL4 Promotes Lung Adenocarcinoma Progression by Enhancing the Generation of Myeloid-Derived Suppressor Cell-Secreted TGF-β1.外泌体PVRL4通过增强髓源性抑制细胞分泌的TGF-β1的生成促进肺腺癌进展。
Thorac Cancer. 2025 Jan;16(2):e15495. doi: 10.1111/1759-7714.15495. Epub 2024 Dec 26.
5
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.恩杂鲁胺治疗既往接受过治疗的晚期头颈癌患者的II期试验。
J Clin Oncol. 2025 Feb 10;43(5):578-588. doi: 10.1200/JCO.24.00646. Epub 2024 Oct 31.
6
Emerging Targets in Non-Small Cell Lung Cancer.非小细胞肺癌的新兴靶点。
Int J Mol Sci. 2024 Sep 18;25(18):10046. doi: 10.3390/ijms251810046.
7
Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer.恩杂鲁胺与帕博利珠单抗联合治疗局部晚期或转移性尿路上皮癌成功开发的机制性见解。
Cancers (Basel). 2024 Sep 4;16(17):3071. doi: 10.3390/cancers16173071.
8
Amniotic fluid proteomic analysis identifies IL1RL1, APOE, and NECTIN4 as new biomarkers for preterm birth.羊水蛋白质组分析鉴定出 IL1RL1、APOE 和 NECTIN4 是早产的新生物标志物。
BMC Pregnancy Childbirth. 2024 Aug 12;24(1):530. doi: 10.1186/s12884-024-06734-2.
9
Therapeutic prospects of nectin-4 in cancer: applications and value.Nectin-4在癌症治疗中的前景:应用与价值
Front Oncol. 2024 Mar 28;14:1354543. doi: 10.3389/fonc.2024.1354543. eCollection 2024.
10
Increased levels of nectin-4 as a serological marker for pre-eclampsia.作为子痫前期血清学标志物的NECTIN-4水平升高。
Fujita Med J. 2023 Aug;9(3):200-205. doi: 10.20407/fmj.2022-027. Epub 2022 Dec 27.
这完全是新潮的……搭乘卵巢癌研究的新浪潮。
Cancer Res. 2016 Jan 1;76(1):10-7. doi: 10.1158/0008-5472.CAN-15-1382. Epub 2015 Dec 15.
4
Claudin 1 in Breast Cancer: New Insights.乳腺癌中的Claudin 1:新见解。
J Clin Med. 2015 Nov 27;4(12):1960-76. doi: 10.3390/jcm4121952.
5
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.完整的LKB1活性是休眠性卵巢癌球体存活所必需的。
Oncotarget. 2015 Sep 8;6(26):22424-38. doi: 10.18632/oncotarget.4211.
6
Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer.Nectin-4表达对人类胰腺癌的肿瘤增殖、血管生成及患者预后有影响。
J Exp Clin Cancer Res. 2015 Mar 28;34(1):30. doi: 10.1186/s13046-015-0144-7.
7
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
8
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.间皮细胞通过分泌纤连蛋白促进早期卵巢癌转移。
J Clin Invest. 2014 Oct;124(10):4614-28. doi: 10.1172/JCI74778. Epub 2014 Sep 9.
9
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer.膜粘连蛋白-4 的表达是 T1-T2、N0 腔A型早期乳腺癌远处复发的危险因素。
Oncogenesis. 2014 Sep 1;3(9):e118. doi: 10.1038/oncsis.2014.32.
10
The interplay of cell-cell and cell-substrate adhesion in collective cell migration.集体细胞迁移中细胞间和细胞与基质黏附的相互作用。
J R Soc Interface. 2014 Nov 6;11(100):20140684. doi: 10.1098/rsif.2014.0684.